Quartolio

New York, United States Founded: 2016 • Age: 10 yrs
AI-based data research platform to manage patents and clinical trials

About Quartolio

Quartolio is a company based in New York (United States) founded in 2016 by Nicole Bishop. Quartolio has raised $350 thousand across 2 funding rounds from investors including Gener8tor and IndieBio. Quartolio operates in a competitive market with competitors including Medrio, L7 Informatics, MDClone, Clinical Research IO and VivoSense, among others.

Key Metrics
  • Total Equity Funding
    $350K (USD)

    in 2 rounds

  • Latest Funding Round
    $100K (USD), Seed

    Jun 2023

  • Investors
    Gener8tor

    & 1 more

Funding Insights of Quartolio

Quartolio has successfully raised a total of $350K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $100 thousand completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $350,000
  • Total Rounds 2
  • Last Round Seed β€” $100,000
  • First Round $250,000

    (Sep 2018)

  • Investors Count 2

All 2 funding rounds of Quartolio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2023$100,000Seed–Gener8tor
–
Sep 2018$250,000Seed–IndieBio
–
Valuation history

2 investors in total: 2 institutional.

Investors in Quartolio

Quartolio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Gener8tor and IndieBio.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Startups are accelerated via a 12-week program with funding support.
2012gener8tor.comMadison, United States
Biotech startups are accelerated through IndieBio's focused programs.
–indiebio.coSan Francisco, United States
Premium access

Investor details for Quartolio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Quartolio

1 people are tracked at Quartolio (1 in leadership).

NameRoleGroup
Nicole Bishop
Founder & CEOLeadership
Premium access

Complete people profiles for Quartolio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Quartolio

3 dated milestones of Quartolio across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Quartolio is founded.
  2. Funding First funding round of $250K.
  3. Funding Latest funding round, Seed, of $100K.

Competitors of Quartolio

Quartolio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medrio, L7 Informatics, MDClone, Clinical Research IO and VivoSense, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
medrio.com2005San Francisco, United States$32.03M120
Cloud-based eClinical software for clinical trials is provided.
l7informatics.com2012Austin, United States$54.97M126
Clinical trial workflow management software is provided for laboratories.
mdclone.com2016–$104M–
Provider of software that creates synthetic medical records for fictitious patients
clinicalresearch.io2015Boston, United States$16.7M16
Clinical trial management software is provided for research sites.
vivosense.com2010San Diego, United States$27.46M–
Wearable sensor research analysis platform
castoredc.com2012New York, United States$63.25M–
Electronic data capture platforms for medical research are offered.
bigomics.ch2018Bellinzona, Switzerland$1.85M–
Cloud-based self-service data analytics platform for healthcare is developed.
threadresearch.com2012Tustin, United States$50M7
Provider of patient research studies software
Premium access

Detailed competitors of Quartolio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to Quartolio

10 companies that operate in the same segment as Quartolio (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Quartolio

Quartolio was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Quartolio is headquartered in New York, United States. It is registered at New York, New York, United States.

Nicole Bishop is the current CEO of Quartolio. They have also founded this company.

Quartolio is a funded company, having raised a total of $350K across 2 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Sep 2018.

Quartolio was founded in 2016 in New York, United States, within the AI-driven data research sector. An platform is provided for exploring and collecting metadata on patents and clinical trials, alongside managing insights from public datasets. Annotations are enabled for recruitment processes, while machine learning is applied to patent oversight. Citations are transformed for research across sources, with integrations to reference tools and exports in BibTeX or RIS formats.

Quartolio's top competitors include L7 Informatics, MDClone and Medrio.

Quartolio has 2 investors. Key investors include Gener8tor, and IndieBio.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available